Vita Therapeutics Relocates to University of Maryland BioPark

Published on :

The University of Maryland (UM) BioPark announced today that Vita Therapeutics, a cell engineering company harnessing the power of genetics to develop cellular therapies to treat muscular dystrophies and solid tumors, has established offices and laboratory space within approximately 10,000 square feet of leased space in the BioPark. Vita Therapeutics will leverage the new space to bring together its 25+-person team under one roof for the first time with the goal of progressing its co-lead programs, VTA-100 and VTA-300. The company uses induced pluripotent stem cell (iPSC) technology to engineer specific cell types designed to replace those that are defective in patients.

Baltimore Medtech Sector a Key Asset for Ascending Biotech Cluster, Part Two

Published on :

This is Part Two of our series on the vibrant Baltimore medtech ecosystem gaining significant momentum in Baltimore. Part One featured five exciting companies, including CoapTech, JuneBrain, ClearMask, LifeSprout, and NextStep Robotics. 

Baltimore MedTech Sector a Key Asset for Ascending Biotech Cluster, Part One

Published on :

BioBuzz has been reporting on myriad medtech university system spinouts and maturing companies from the Baltimore area for a number of years; we’ve featured a number of exciting and promising individual companies. However, as we’ve stepped back a bit to examine more recent Baltimore biohub developments, it’s become clear that there is an unmistakable groundswell of medtech activity that’s transforming the Baltimore life sciences sector.